课题基金 / 基金详情

The Function of NKT Cells During T Cruzi Infection

The Function of NKT Cells During T Cruzi Infection
T Cruzi 感染期间 NKT 细胞的功能
批准号:
6610985
负责人:
STUART J KAHN
金额:
$38.48万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2005-05-31

项目摘要

项目成果

STUART J KAHN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract) This project's long-term goals are to understand mechanisms of chronic inflammatory diseases. Infections initiate or perpetuate many chronic inflammatory diseases. Trypanosoma cruzi chronically infects mice and is an excellent system to investigate mechanisms of infection-induced chronic inflammation. Natural killer T (NKT) cells appear to function as sentinels that inhibit unwanted responses, but when infections occur they can rapidly respond by initiating protective responses. NKT cells are highly sensitive to activation-induced cell death, and their repeated stimulation leads to death or altered Th cytokine production. Many chronic inflammatory and autoimmune diseases are associated with NKT cell populations that are diminished or have altered Th cytokine production. The effect of chronic stimulation or chronic infection on NKT cells is unknown. A candidate antigen of NKT cells, glycophosphoinositol (GPI), is abundantly expressed by T. cruzi. During T. cruzi infection the function of NKT cells in the protective and chronic inflammatory responses have not been examined. This application's specific aims are to determine during T. cruzi infection the function of NKT cells in: the protective immune response; the regulation of a major MHCII CD4 IFNy response; and the chronic inflammatory response. These responses will be analyzed in wild type mice, NKT cell-deficient mice, and NKT cell-deficient mice adoptively transferred with wild type NKT cells or NKT cells lacking effector functions using cellular immunological and histological techniques. Completion of these aims will provide important insights into NKT cell functions during protective and pathologic immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase 1 Randomized Single Oral Dose Four Period Cross-Over Study Investigating Omnitram Dose Proportionality and Food Effect in Normal Human Subjects
  • 批准号:
    10372803
  • 项目类别:
  • 资助金额:
    $8.02万
  • 财政年份:
    2019
  • 负责人:
    STUART J KAHN
  • 依托单位:
A Phase 1 Randomized Single Oral Dose Four Period Cross-Over Study Investigating Omnitram Dose Proportionality and Food Effect in Normal Human Subjects
  • 批准号:
    10029002
  • 项目类别:
  • 资助金额:
    $120.48万
  • 财政年份:
    2019
  • 负责人:
    STUART J KAHN
  • 依托单位:
HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients
  • 批准号:
    9789451
  • 项目类别:
  • 资助金额:
    $142.44万
  • 财政年份:
    2018
  • 负责人:
    STUART J KAHN
  • 依托单位:
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
  • 批准号:
    10189528
  • 项目类别:
  • 资助金额:
    $65.14万
  • 财政年份:
    2017
  • 负责人:
    STUART J KAHN
  • 依托单位:
海外基金